Dr. Ayomide Owodunni helps FemTech founders and investors ensure products and strategies are credible and compliant.
In a busy hospital in Nigeria, Dr. Ayomide observed women navigating critical health challenges. Some were unclear about their cycles, others had been dismissed by previous providers, and many managed symptoms silently. Clinical practice allowed her to help one woman at a time, but she recognized the potential to impact millions if access to credible information came earlier.
This insight prompted a career shift. Dr. Ayomide left clinical practice to enter the rapidly evolving world of FemTech, where startups are developing innovative solutions for women’s health. She quickly noticed a recurring issue: many companies were advancing bold products and messaging without sufficient evidence. Claims often went unchecked, validation studies were misaligned, and communications risked undermining trust.
Recognizing this gap, Dr. Ayomide became a FemTech Credibility Advisor, bridging clinical knowledge, regulatory requirements, and startup innovation. “Most FemTech companies move fast, shipping features, crafting claims, and raising capital, without fully understanding how these decisions will be reviewed by regulators, investors, and informed consumers. I help them address these areas early, preventing credibility challenges that could affect trust and growth,” she explains.
From Clinic to Strategic Impact
Dr. Ayomide’s expertise originates from direct patient care. Witnessing the limitations of individual interventions in women’s healthcare motivated her to scale her impact strategically. Her combination of clinical knowledge and understanding of regulatory pathways positions her uniquely to advise startups navigating complex medical, investor, and compliance landscapes.
Her work has been featured in Women of Wearables, where she discussed designing FemTech solutions accessible to all women, and in FutureFemHealth, analyzing why startups face challenges with clinical credibility. These features reflect her ability to clarify a sector where innovation can sometimes outpace validation.
The Four Pillars of Credibility
Dr. Ayomide offers four core services to help startups anticipate and mitigate credibility risks:
- Better Woman Health Newsletter
A free weekly subscription providing clinical insights on how to build products, claims, and strategies that can withstand regulatory scrutiny, investor due diligence, and clinical reality before credibility mistakes become expensive and hard to fix. - FemTech Credibility Audit
A 5–10 day review of product claims, validation strategies, pitch materials, website content, and clinical advisor structures. The audit provides startups with a clear analysis of evidence gaps and a risk-rated action plan to support investor and regulatory scrutiny. - Credibility Advisory Retainer
An ongoing partnership offering guidance for product development, messaging, fundraising, and regulatory strategy. Monthly sessions help startups plan responsibly and communicate clearly with stakeholders. - Launch and Fundraise Readiness Review
Focused on high-stakes milestones like fundraising, public launches, or regulatory submissions, this intensive review identifies potential credibility issues and provides actionable recommendations for addressing them before they escalate.
Why Dr. Ayomide Stands Out
Unlike traditional consultants, Dr. Ayomide combines clinical expertise with strategic insight. She identifies blind spots, validates claims, and helps startups communicate information with confidence and accuracy. Her preventative approach ensures companies consider credibility early in the process rather than reactively.
Her human-centered approach emphasizes clarity and usability. She translates complex regulatory and clinical concepts into actionable strategies, helping founders and investors navigate challenges without unnecessary jargon.
Supporting Women and Investors
Dr. Ayomide’s work focuses on fostering trust and transparency in FemTech, helping startups integrate clinical rigor, responsible messaging, and investor confidence. Her approach supports informed decision-making by both founders and investors in a fast-moving sector.
“Women deserve solutions backed by credible evidence. Investors deserve clarity about the products they support. My role is to provide both sides with the information they need to make informed choices,” she says.
Engage with Dr. Ayomide
For FemTech founders, investors, and healthcare innovators seeking guidance on credibility, Dr. Ayomide offers a unique combination of clinical, regulatory, and strategic expertise. To learn more about her services or subscribe to her newsletter:
Dr. Ayomide O. continues to shape the landscape of FemTech by helping companies integrate scientific rigor, clear communication, and strategic insight, supporting responsible innovation in women’s health.
